Bear of the Day: Bayer (BAYRY)
July 02, 2010 at 04:03 AM EDT
We are concerned about Bayer’s (BAYRY) disappointing performance of the CropScience segment in the most recent quarter. Moreover, the delay in approval of Xarelto also concerns us. Furthermore, the failure of Nexavar to prolong the overall survival in patients suffering from advanced non-squamous non-small cell lung cancer (NSCLC) in a late-stage study is a setback for [...]
